BriaCell Therapeutics (BCTX) Long-Term Investments (2021 - 2026)
BriaCell Therapeutics' Long-Term Investments came in at $750,982 for fiscal Q3 2026 (quarter ended Apr 30, 2026), up 51.2% from $496,653 a year earlier and up 28.9% from the prior quarter.
Powered by 
Analysis
BriaCell Therapeutics (BCTX) Long-Term Investments (2021 - 2026) Analysis & Trends
At the end of FY2025 (ended Jul 31, 2025), BriaCell Therapeutics' Long-Term Investments was $524,278, up 25.3% from FY2024.
- Long-Term Investments carries a four-year compound annual growth rate of 2162.7% (FY2021 to FY2025).
- Going back by fiscal year, Long-Term Investments was $418,490 in FY2024, $2.00 in FY2023 (unchanged), $2.00 in FY2022 (unchanged) and $2.00 in FY2021.
- The fiscal Q3 2026 figure represents the highest quarterly Long-Term Investments in data going back to fiscal Q4 2021.
- Year-over-year, Long-Term Investments has increased for six consecutive quarters, with growth averaging 33.9% over the last six quarters.
- The year-over-year growth in Long-Term Investments has ranged between 0.0% (fiscal Q4 2022) and 61.3% (fiscal Q2 2025) over the last five years.
- Business Quant data shows BCTX's Long-Term Investments at $582,455 (Q2 2026), $554,448 (Q1 2026) and $524,278 (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 266.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.22 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 69.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 2.62 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 1.56 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 5.79 Bn |
| 10 | BriaCell Therapeutics | 31.03 Mn | 30.38 Mn | - | 750,982.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 750,982.00 |
| Jan 31, 2026 | 582,455.00 |
| Oct 31, 2025 | 554,448.00 |
| Jul 31, 2025 | 524,278.00 |
| Apr 30, 2025 | 496,653.00 |
| Jan 31, 2025 | 454,391.00 |
| Oct 31, 2024 | 421,975.00 |
| Jul 31, 2024 | 418,490.00 |
| Apr 30, 2024 | 469,658.00 |
| Jan 31, 2024 | 281,655.00 |
| Oct 31, 2023 | 2.00 |
| Jul 31, 2023 | 2.00 |
| Apr 30, 2023 | 2.00 |
| Jan 31, 2023 | 2.00 |
| Oct 31, 2022 | 2.00 |
| Jul 31, 2022 | 2.00 |
| Jul 31, 2021 | 2.00 |
API Access
BriaCell Therapeutics Long-Term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-investments&ticker=BCTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-investments", "ticker": "BCTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-investments&ticker=BCTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();